Australia markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.6100+0.0600 (+1.32%)
At close: 04:00PM EDT
4.6800 +0.07 (+1.52%)
After hours: 06:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.23M
Enterprise value 8.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.66
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.42

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 369.17%
S&P500 52-week change 332.65%
52-week high 38.6500
52-week low 31.3700
50-day moving average 33.4005
200-day moving average 33.2589

Share statistics

Avg vol (3-month) 3815.92k
Avg vol (10-day) 3601.64k
Shares outstanding 53.52M
Implied shares outstanding 63.52M
Float 81.64M
% held by insiders 153.33%
% held by institutions 12.38%
Shares short (13 Sept 2024) 4652.49k
Short ratio (13 Sept 2024) 40.34
Short % of float (13 Sept 2024) 4133.71%
Short % of shares outstanding (13 Sept 2024) 418.53%
Shares short (prior month 15 Aug 2024) 429.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 313 Aug 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-53.44%
Return on equity (ttm)-102.31%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.12M
Diluted EPS (ttm)-2.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.12M
Total cash per share (mrq)2.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.59
Book value per share (mrq)1.73

Cash flow statement

Operating cash flow (ttm)-6.82M
Levered free cash flow (ttm)-4.43M